Search Results
Sep 03, 2026, 13:54 ET Huawei ra mắt loạt sản phẩm chủ lực thế hệ tiếp theo tại sự kiện ra mắt sản phẩm đổi mới sáng tạo toàn cầu "Chase the Wild" tại Munich
mang tính tham khảo và không nên được sử dụng làm cơ sở để chẩn đoán hoặc điều trị y tế.[iii] Tính năng này không dành cho mục đích y tế. Kết quả chỉ mang tính tham khảo và không nên được sử dụng làm cơ sở để chẩn đoán hoặc điều trị y tế.
More news about: Huawei
Sep 03, 2026, 13:31 ET Datavault AI, Inc. (DVLT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Plaintiff and other Class members, as alleged herein; (ii) artificially inflate and maintain the market price of Datavault AI securities; and (iii) cause Plaintiff and other members of the Class to purchase or otherwise acquire Datavault AI securities and options at artificially inflated prices.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Sep 03, 2026, 13:25 ET Huawei revelou seus produtos emblemáticos de última geração durante o evento global de lançamento "Chase the Wild", realizado em Munique
diagnóstico ou tratamento médico.[iii] Essa funcionalidade não se destina ao uso médico. Os resultados são apenas para referência e não devem ser usados como base para diagnóstico ou tratamento
More news about: Huawei
Sep 03, 2026, 13:14 ET Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Revita's clinical, regulatory, and commercial prospects were overstated, as was the REMAIN-1 Midpoint Cohort's ability to assess Revita's efficacy; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.Contact Us To Participate or Learn More:If
More news about: Law Offices of Howard G. Smith
Sep 03, 2026, 13:08 ET Gan & Lee a Menarini Group uzavřely partnerství k prosazení přípravku bofanglutid v Evropě
podkožní podávání jednou za dva týdny, což snižuje frekvenci podávání o 50 % ve srovnání s léky GLP-1 RA podávanými jednou týdně. Klíčová studie fáze III v Číně a studie fáze II ve Spojených státech zaměřené na regulaci hmotnosti u dospělých s obezitou nebo nadváhou splnily své primární cíle, čímž prokázaly
More news about: Menarini Industrie Farmaceutiche Riunite
Sep 03, 2026, 13:01 ET Gan & Lee et le groupe Menarini s'associent pour faire progresser le bofanglutide en Europe
semaines, ce qui réduit la fréquence d'administration de 50 % par rapport aux agonistes du GLP-1 à administration hebdomadaire . L'étude pivot de phase III menée en Chine et l'étude de phase II menée aux États-Unis sur la gestion du poids chez les adultes souffrant d'obésité ou de surpoids ont toutes deux
More news about: Menarini Industrie Farmaceutiche Riunite
Sep 03, 2026, 12:33 ET Huawei presenta i prodotti di nuova generazione all'evento globale di lancio "Chase the Wild" a Monaco di Baviera
diagnosi o trattamenti medici.[Iii] La funzione non è destinata a uso medico. I risultati sono solo di riferimento e non devono essere utilizzati come base per diagnosi o trattamenti
More news about: Huawei
Sep 03, 2026, 12:26 ET Huawei onthult vlaggenschipproducten van de volgende generatie tijdens wereldwijd innovatief productlanceringsevenement "Chase the Wild" in München
behandeling worden gebruikt.[iii] De functie is niet bedoeld voor medisch gebruik. De resultaten dienen uitsluitend als referentie en mogen niet als basis voor een medische diagnose
More news about: Huawei
Sep 03, 2026, 12:00 ET Aevex Corp. (AVEX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
significant portion of its Aevex holdings in the SPO, and the entirety of the SPO's net proceeds went to Madison, with Aevex earning zero from the SPO; (iii) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable
More news about: Law Offices of Howard G. Smith
Sep 03, 2026, 11:56 ET California Baptist University expands career preparation, announces Modern Woodmen sponsorship
opportunities in 2018."CBU has been an integral part of our recruiting efforts since we first came to campus in 2018," said Bennett L. Sperber III, managing director at Modern Woodmen Fraternal Financial. "We see strong alignment between CBU's values and our own, but we also see students who are
More news about: California Baptist University
Sep 03, 2026, 11:00 ET Havoc and Rune Technologies Announce Integration to Deliver Autonomous Logistics at the Edge
the field. On August 16, 2026, Rune Technologies successfully integrated TyrOS with Havoc's autonomous drones during xTech Overwatch's Pegasus Charge III exercise at Fort Hood, Texas, where the two companies completed an end-to-end autonomous resupply mission for the first time, in a live operational setting.About
More news about: Havoc AI
Sep 03, 2026, 10:41 ET Huawei prezentuje flagowe produkty nowej generacji podczas światowej premiery „Chase the Wild" w Monachium
podstawy diagnozy ani leczenia.[iii] Funkcja nie jest przeznaczona do zastosowań medycznych. Wyniki mają charakter wyłącznie orientacyjny i nie powinny stanowić podstawy diagnozy
More news about: Huawei
Sep 03, 2026, 10:07 ET REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact SueWallSt
Market impact notice: REGN shares allegedly lost $102.09 from the Class Period high after disclosures about a Phase III Fianlimab-Libtayo protocol change and failed primary endpoint challenged earlier positive trial-risk messaging.NEW YORK,
More news about: SueWallSt.com
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT
for a $40,000 fine and a three-year ban from participating in a penny stock offering. Nor did the Company's announcement disclose that Edward Withrow III ("Withrow"), an individual listed as inventor alongside Defendant Bradley on multiple Data Vault Holdings patents, had a previous felony
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Intuit Inc. and Certain Officers - INTU
marketing products and services in the United States. The Company has four reportable business segments: (i) Global Business Solutions; (ii) Consumer; (iii) Credit Karma; and (iv) ProTax. Intuit's Consumer segment provides do-it-yourself ("DIY") and assisted income tax preparation products and services
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
joining the class action]On April 29, 2026, during during Regeneron's first quarter earnings call, the Company disclosed that the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for "analysis of progression-free survival." On
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS
therapy. The REMAIN-1 study is designed to include three distinct patient cohorts: (i) the REVEAL-1 Cohort; (ii) the REMAIN-1 Midpoint Cohort; and (iii) the REMAIN-1 Pivotal Cohort.At all relevant times, Defendants touted Revita's efficacy as observed in interim data readouts from the REVEAL-1
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
safe than Defendants had led investors to believe; (ii) accordingly, ARD-101's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The truth began to emerge on February 27,
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Microvast Holdings, Inc. and Certain Officers - MVST
ability to reach its margin targets; (ii) Defendants overstated Microvast's ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The market received its first inkling of
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Wix.com Ltd. and Certain Officers - WIX
relative to those offered by other companies; (ii) Wix had understated the costs associated with developing and promoting its AI product offerings; (iii) accordingly, Defendants overstated the commercial and financial benefits of Wix's AI product offerings; and (iv) as a result, Defendants' public statements
More news about: Pomerantz LLP
Sep 03, 2026, 09:29 ET Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices
study published by IQVIA in August 2025 found that non-small-molecule assets, including advanced modalities, accounted for 46% of Phase I–III clinical trial starts in 2024, up from 38% five years earlier."Life sciences companies increasingly need partners with the specialized expertise,
More news about: Resonant Clinical Solutions
Sep 03, 2026, 09:29 ET Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices
study published by IQVIA in August 2025 found that non-small-molecule assets, including advanced modalities, accounted for 46% of Phase I–III clinical trial starts in 2024, up from 38% five years earlier."Life sciences companies increasingly need partners with the specialized expertise,
More news about: Resonant Clinical Solutions
Sep 03, 2026, 09:19 ET Yatsen Group Releases 2025 ESG Report: The Vision of a World-Class Beauty Innovation Pioneer Through Long-Term Value
discrimination, harassment, privacy breaches, money laundering, or insider trading were reported.Level III Security Certification: The group's core systems earned Level III Certification in Cybersecurity Graded Protection Assessment from the Guangzhou Public Security Bureau.Strengthened
More news about: Yatsen Holding Limited
Sep 03, 2026, 09:17 ET Gan & Lee i Menarini Group łączą siły na rzecz rozwoju bofanglutydu w Europie
pozwala zmniejszyć częstotliwość podawania o 50% w porównaniu z agonistami receptora GLP-1 podawanymi raz w tygodniu. Zarówno kluczowe badanie fazy III prowadzone w Chinach, jak i badanie fazy II prowadzone w Stanach Zjednoczonych, dotyczące kontroli masy ciała u osób dorosłych z otyłością lub nadwagą,
More news about: Menarini Industrie Farmaceutiche Riunite
Sep 03, 2026, 09:14 ET Společnost Huawei představila na globální akci Chase the Wild v Mnichově novou generaci vlajkových produktů
lékařskou diagnózu ani léčbu. [iii] Tato funkce není určena k lékařským účelům. Výsledky jsou pouze orientační a nesmí sloužit jako podklad pro lékařskou diagnózu ani léčbu.
More news about: Huawei